VERO CELL CULTURE ATTENUATED LIVE CAMELPOX VACCINE FOR PROTECTION OF CAMELS AGAINST CAMEPLOX

摘要

The present invention relates to the development of a live attenuated vaccine for control of camelpox in camels. Camelpox infection is most significant in camels as it causes substantial losses through high morbidity, mortality, decreased productivity and hides damage. The vaccine developed here can be used to protect camels from clinical disease when administered at a dose of 10 TCID50 per animal. The vaccine is given intra-dermally at the ventral aspect of the caudal fold in a volume of 0.5 ml per animal. The vaccine is expected to bring down the incidence of the disease contributing eventually to the enhanced productivity of camels. The vaccine developed, described and claimed in this patent, can effectively be used for control of camelpox.